| Serial Number | 97087368 |
| Word Mark | TMIT |
| Filing Date | Friday, October 22, 2021 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Monday, March 6, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 13, 2022 |
| Pseudo Mark | T MIT |
| Goods and Services | Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of diagnosis and treatment of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the field of cancer and immunological diseases; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Monday, March 6, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Crossbow Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Crossbow Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Monday, March 6, 2023 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Monday, March 6, 2023 | ABANDONMENT - AFTER PUBLICATION |
| Saturday, March 4, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Monday, October 3, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, September 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 13, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 24, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 9, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 8, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 8, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 8, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 8, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 1, 2022 | ASSIGNED TO EXAMINER |
| Monday, November 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 26, 2021 | NEW APPLICATION ENTERED |